Immediate Effects of Paraffin Wax Therapy on Forearm and Hand Muscle Stiffness and Pain in Carpal Tunnel Syndrome
Paraffin-CTS
1 other identifier
interventional
24
1 country
1
Brief Summary
This randomized controlled trial aims to investigate the immediate effects of paraffin wax therapy on muscle stiffness and pain among patients diagnosed with Carpal Tunnel Syndrome (CTS). The intervention involves immersing the hand and forearm in paraffin wax at 42-44 °C for 20 minutes. Stiffness will be measured using the MyotonPro device, and pain will be evaluated using standard visual scales.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedStudy Start
First participant enrolled
November 25, 2025
CompletedFirst Posted
Study publicly available on registry
December 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2025
CompletedDecember 3, 2025
December 1, 2025
10 days
November 19, 2025
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in muscle stiffness parameters
Change in MyotonPro-derived muscle stiffness (Newton per metre) of selected forearm and hand muscles (adductor pollicis brevis, flexor digitorum superficialis, extensor carpi radialis brevis, flexor carpi ulnaris ). For each site, three consecutive impulses separated by at least 10 seconds will be averaged. The primary comparison is the between-group difference (paraffin vs rest) in pre- to post-session change scores.
Immediately before the intervention and within 5 minutes after completion of the 20-minute paraffin/rest session (same visit)
Secondary Outcomes (1)
Change in pain intensity
Immediately before the intervention and within 5 minutes after completion of the 20-minute paraffin/rest session (same visit).
Study Arms (2)
Paraffin Wax Therapy
EXPERIMENTALParticipants receive a single session of paraffin wax therapy to the affected hand and forearm. Muscle stiffness and pain are assessed immediately before and after the session.
Rest / Control
OTHERParticipants rest quietly for 20 minutes in a comfortable position with the forearm supported, without receiving paraffin wax or any other physical/thermal modality. Muscle stiffness and pain are assessed at the same time points as in the experimental arm.
Interventions
Participants in the experimental arm receive paraffin wax therapy to the affected hand and forearm. Melted paraffin is maintained at approximately 42-44 °C. Using a brush-on technique, 10 consecutive layers of wax are applied, and the limb is then covered with a plastic glove and towel to retain heat. The participant remains seated with the forearm supported in a relaxed position for 20 minutes. Muscle stiffness (MyotonPro) and pain are measured immediately before and within 5 minutes after the session.
Participants in the control arm rest quietly for 20 minutes in a comfortable seated or supine position with the forearm supported. No thermal, manual or exercise-based treatment is provided during this period. Muscle stiffness (MyotonPro) and pain are measured immediately before and within 5 minutes after the rest period, using the same procedures and time points as in the experimental arm.
Eligibility Criteria
You may qualify if:
- Clinically diagnosed carpal tunnel syndrome.
- Age between 18 and 65 years.
- Apparently healthy, without a known chronic systemic disease (other than CTS).
- No history of other chronic musculoskeletal or neurological disorders.
You may not qualify if:
- Previous surgery on the affected wrist or hand.
- Systemic conditions affecting nerve function (e.g., diabetes mellitus, thyroid disease)
- Cardiovascular disease or uncontrolled hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amasya Universitycollaborator
- Erzurum Technical Universitylead
- Bangor Universitycollaborator
Study Sites (1)
Erzurum Şehir Hastanesi
Erzurum, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 3, 2025
Study Start
November 25, 2025
Primary Completion
December 5, 2025
Study Completion
December 6, 2025
Last Updated
December 3, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data (IPD) from this trial. Summary results and aggregate data will be disseminated through peer-reviewed publications and conference presentations.